130 related articles for article (PubMed ID: 6156338)
1. Relative effects of sulfinpyrazone and ibuprofen on canine platelet function and prostaglandin-mediated coronary vasodilation.
Goldstein RE; Davenport NJ; Capurro NL; Lipson LC; Bonow RO; Shulman NR; Epstein SE
J Cardiovasc Pharmacol; 1980; 2(4):399-409. PubMed ID: 6156338
[No Abstract] [Full Text] [Related]
2. Relative effects of aspirin on platelet aggregation and prostaglandin-mediated coronary vasodilatation in the dog.
Capurro NL; Lipson LC; Bonow RO; Goldstein RE; Shulman NR; Epstein SE
Circulation; 1980 Dec; 62(6):1221-7. PubMed ID: 7438358
[TBL] [Abstract][Full Text] [Related]
3. A metabolite of sulphinpyrazone that is largely responsible for the effect of the drug on the platelet prostaglandin pathway.
Pay GF; Wallis RB; Zelaschi D
Biochem Soc Trans; 1980 Dec; 8(6):727-8. PubMed ID: 7461266
[No Abstract] [Full Text] [Related]
4. Antiplatelet agents: rationale and results.
Kelton JG
Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
[No Abstract] [Full Text] [Related]
5. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Lorenz R; Siess W; Weber PC
Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
[TBL] [Abstract][Full Text] [Related]
6. The effect of ibuprofen dose on rabbit platelet aggregation and aortic pgi2 synthesis.
Adesuyi SA; Ellis EF
Thromb Res; 1982 Nov; 28(4):581-5. PubMed ID: 6761894
[No Abstract] [Full Text] [Related]
7. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
Hatmi M; del Maschio A; Lefort J; de gaetano G; Vargaftig BB; Cerletti C
J Pharmacol Exp Ther; 1987 May; 241(2):623-7. PubMed ID: 3106620
[TBL] [Abstract][Full Text] [Related]
8. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
Mehta J
JAMA; 1983 May; 249(20):2818-23. PubMed ID: 6341645
[No Abstract] [Full Text] [Related]
9. Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
Pedersen AK; FitzGerald GA
Clin Pharmacol Ther; 1985 Jan; 37(1):36-42. PubMed ID: 3917387
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandins and precursors in platelet function.
Smith JB; Ingerman CM; Silver MJ
Ciba Found Symp; 1975; 35():207-24. PubMed ID: 776549
[No Abstract] [Full Text] [Related]
11. Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites.
Del Maschio A; Livio M; Cerletti C; De Gaetano G
Eur J Pharmacol; 1984 Jun; 101(3-4):209-14. PubMed ID: 6432556
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandins and thromboxane A2 on the coronary circulation of adult dogs and puppies.
Wang HH; Kulkarni PS; Eakins KE
Eur J Pharmacol; 1980 Aug; 66(1):31-41. PubMed ID: 7408964
[TBL] [Abstract][Full Text] [Related]
13. Platelets and prostaglandins in sudden death: therapeutic implications.
Gelman JS; Mehta J
Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
[No Abstract] [Full Text] [Related]
14. [Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Hansen MS; Birgens HS
Ugeskr Laeger; 1980 Jan; 142(5):303-5. PubMed ID: 6243811
[No Abstract] [Full Text] [Related]
15. Rat platelets aggregate in the absence of endogenous precursors of prostaglandin endoperoxides.
Bult H; Bonta IL
Nature; 1976 Dec; 264(5585):449-51. PubMed ID: 1004576
[No Abstract] [Full Text] [Related]
16. Effect of three nonsteroidal anti-inflammatory agents on platelet function and prostaglandin synthesis in vitro.
McIntyre BA; Philp RB
Thromb Res; 1978 Jan; 12(1):67-77. PubMed ID: 644561
[No Abstract] [Full Text] [Related]
17. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
[No Abstract] [Full Text] [Related]
18. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
Clemmons RM; Meyers KM
Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
[TBL] [Abstract][Full Text] [Related]
19. Effect of minoxidil on platelet function and the synthesis of prostaglandins in platelets.
O'Barr TP; Swanson EW; Fitzpatrick JE; Corby DG
J Lab Clin Med; 1989 Nov; 114(5):575-8. PubMed ID: 2553835
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of inhibitors of platelet release and aggregation.
Rosenberg JC; Sell TL
Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
